Table 2.
Correlations Between Baseline PDFF and Other Variables
| Correlation coefficient (r) |
P | |
|---|---|---|
| Liver function tests | ||
| Total bilirubin | 0.32 | <.05 |
| ALT | 0.40 | <.002 |
| AST | 0.22 | .30 |
| Alkaline phosphatase | 0.17 | .60 |
| Histopathologic features | ||
| Steatosis grade | 0.78 | <.001 |
| Lobular inflammation | 0.22 | .49 |
| Fibrosis stage | −0.58 | <.001 |
| Hepatocyte ballooning | 0.37 | .08 |
| NAS | 0.54 | <.001 |
| Metabolic features | ||
| Diabetes diagnosis | n/a | .87 |
| Duration of diabetes diagnosis | 0.39 | .15 |
| Glycosylated hemoglobin (HbA1c) | 0.24 | .26 |
| Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) | 0.32 | .17 |
| AST to Platelet Ratio Index (APRI) Score | 0.14 | .72 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase.